241 related articles for article (PubMed ID: 11462006)
1. Proteolysis of monomeric recombinant rotavirus VP4 yields an oligomeric VP5* core.
Dormitzer PR; Greenberg HB; Harrison SC
J Virol; 2001 Aug; 75(16):7339-50. PubMed ID: 11462006
[TBL] [Abstract][Full Text] [Related]
2. Localization of membrane permeabilization and receptor binding sites on the VP4 hemagglutinin of rotavirus: implications for cell entry.
Tihova M; Dryden KA; Bellamy AR; Greenberg HB; Yeager M
J Mol Biol; 2001 Dec; 314(5):985-92. PubMed ID: 11743716
[TBL] [Abstract][Full Text] [Related]
3. A rotavirus spike protein conformational intermediate binds lipid bilayers.
Trask SD; Kim IS; Harrison SC; Dormitzer PR
J Virol; 2010 Feb; 84(4):1764-70. PubMed ID: 20007281
[TBL] [Abstract][Full Text] [Related]
4. Trypsin cleavage stabilizes the rotavirus VP4 spike.
Crawford SE; Mukherjee SK; Estes MK; Lawton JA; Shaw AL; Ramig RF; Prasad BV
J Virol; 2001 Jul; 75(13):6052-61. PubMed ID: 11390607
[TBL] [Abstract][Full Text] [Related]
5. Location of intrachain disulfide bonds in the VP5* and VP8* trypsin cleavage fragments of the rhesus rotavirus spike protein VP4.
Patton JT; Hua J; Mansell EA
J Virol; 1993 Aug; 67(8):4848-55. PubMed ID: 8392619
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity, antigenicity, and protection efficacy of baculovirus expressed VP4 trypsin cleavage products, VP5(1)* and VP8* from rhesus rotavirus.
Dunn SJ; Fiore L; Werner RL; Cross TL; Broome RL; Ruggeri FM; Greenberg HB
Arch Virol; 1995; 140(11):1969-78. PubMed ID: 7503695
[TBL] [Abstract][Full Text] [Related]
7. The rhesus rotavirus VP4 sialic acid binding domain has a galectin fold with a novel carbohydrate binding site.
Dormitzer PR; Sun ZY; Wagner G; Harrison SC
EMBO J; 2002 Mar; 21(5):885-97. PubMed ID: 11867517
[TBL] [Abstract][Full Text] [Related]
8. Assembly of highly infectious rotavirus particles recoated with recombinant outer capsid proteins.
Trask SD; Dormitzer PR
J Virol; 2006 Nov; 80(22):11293-304. PubMed ID: 16971442
[TBL] [Abstract][Full Text] [Related]
9. Rotavirus capsid protein VP5* permeabilizes membranes.
Denisova E; Dowling W; LaMonica R; Shaw R; Scarlata S; Ruggeri F; Mackow ER
J Virol; 1999 Apr; 73(4):3147-53. PubMed ID: 10074166
[TBL] [Abstract][Full Text] [Related]
10. The VP5 domain of VP4 can mediate attachment of rotaviruses to cells.
Zárate S; Espinosa R; Romero P; Méndez E; Arias CF; López S
J Virol; 2000 Jan; 74(2):593-9. PubMed ID: 10623720
[TBL] [Abstract][Full Text] [Related]
11. Trypsin activation pathway of rotavirus infectivity.
Arias CF; Romero P; Alvarez V; López S
J Virol; 1996 Sep; 70(9):5832-9. PubMed ID: 8709201
[TBL] [Abstract][Full Text] [Related]
12. Rotavirus VP4 Epitope of a Broadly Neutralizing Human Antibody Defined by Its Structure Bound with an Attenuated-Strain Virion.
Jenni S; Li Z; Wang Y; Bessey T; Salgado EN; Schmidt AG; Greenberg HB; Jiang B; Harrison SC
J Virol; 2022 Aug; 96(16):e0062722. PubMed ID: 35924923
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
[TBL] [Abstract][Full Text] [Related]
14. Trypsin is associated with the rotavirus capsid and is activated by solubilization of outer capsid proteins.
Benureau Y; Huet JC; Charpilienne A; Poncet D; Cohen J
J Gen Virol; 2005 Nov; 86(Pt 11):3143-3151. PubMed ID: 16227238
[TBL] [Abstract][Full Text] [Related]
15. Expression and characterization of a novel truncated rotavirus VP4 for the development of a recombinant rotavirus vaccine.
Li Y; Xue M; Yu L; Luo G; Yang H; Jia L; Zeng Y; Li T; Ge S; Xia N
Vaccine; 2018 Apr; 36(16):2086-2092. PubMed ID: 29555220
[TBL] [Abstract][Full Text] [Related]
16. Identification of two independent neutralization domains on the VP4 trypsin cleavage products VP5* and VP8* of human rotavirus ST3.
Padilla-Noriega L; Dunn SJ; López S; Greenberg HB; Arias CF
Virology; 1995 Jan; 206(1):148-54. PubMed ID: 7530390
[TBL] [Abstract][Full Text] [Related]
17. VP5* rearranges when rotavirus uncoats.
Yoder JD; Trask SD; Vo TP; Binka M; Feng N; Harrison SC; Greenberg HB; Dormitzer PR
J Virol; 2009 Nov; 83(21):11372-7. PubMed ID: 19692464
[TBL] [Abstract][Full Text] [Related]
18. Alternative intermolecular contacts underlie the rotavirus VP5* two- to three-fold rearrangement.
Yoder JD; Dormitzer PR
EMBO J; 2006 Apr; 25(7):1559-68. PubMed ID: 16511559
[TBL] [Abstract][Full Text] [Related]
19. Humoral immune responses to VP4 and its cleavage products VP5* and VP8* in infants vaccinated with rhesus rotavirus.
Padilla-Noriega L; Fiore L; Rennels MB; Losonsky GA; Mackow ER; Greenberg HB
J Clin Microbiol; 1992 Jun; 30(6):1392-7. PubMed ID: 1320626
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of rotavirus VP4 in vivo.
Ludert JE; Krishnaney AA; Burns JW; Vo PT; Greenberg HB
J Gen Virol; 1996 Mar; 77 ( Pt 3)():391-5. PubMed ID: 8601772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
